Nominations Open for New Scientific Achievement Award
June 24, 2008
AACR Seeks Submissions for 2008 Susan G. Komen for the Cure - AACR Outstanding Investigator Award for Breast Cancer Research
PHILADELPHIA -The American Association for Cancer Research (AACR), in partnership with Susan G. Komen for the Cure, is currently accepting nominations for the inaugural Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research.
This new award will recognize an investigator whose novel and significant work has had, or may have, a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of breast cancer. The award is intended to honor individuals relatively early in their careers, therefore, nominees must be no more than 50 years old at the time the award is received.
The establishment of this award follows the newly announced partnership between AACR and the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center to jointly present the CTRC-AACR San Antonio Breast Cancer Symposium in 2008. Through AACR's scientific prestige in basic, translational and clinical research, the current strengths of the San Antonio Breast Cancer Symposium will be enhanced to create a more comprehensive program that will advance breast cancer research across the full spectrum of related disciplines. Therefore, nominations of worthy basic, translational and clinical scientists are sought to reflect that advances in breast cancer research will come from all scientific areas.
Nominations may be made by individual investigators who are affiliated with any institution involved in basic cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Candidates may not nominate themselves.
The recipient of the Komen-AACR Award will receive an honorarium of $10,000 and will deliver a 30-minute lecture about his or her research at the 2008 CTRC-AACR San Antonio Breast Cancer Symposium, December 10-14, 2008.
Along with the Outstanding Investigator Award, Susan G. Komen for the Cure will support three additional new initiatives in conjunction with the CTRC-AACR San Antonio Breast Cancer Symposium. In an effort to educate basic scientists and clinicians about the latest advances in each other's fields, Susan G. Komen for the Cure will sponsor the CTRC-AACR San Antonio Breast Cancer Symposium Educational Sessions, addressing emerging targets, signal transduction pathways controlling cell proliferation and cell death in breast cancer, clinical trials and pathobiology.
Additional support from Komen will fund the Susan G. Komen for the Cure-AACR Scholar-in-Training Awards and Minority Scholar Awards for Breast Cancer Research. These awards aim to provide support for outstanding young investigators to attend the symposium and present their highly-meritorious breast cancer research. The ultimate goal is to expand the pool of researchers contributing new and innovative ideas to breast cancer research.
For more information on eligibility criteria, the nomination process and other details about the Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research, please visit the webpage. Nominations for this award should be sent to firstname.lastname@example.org. Inquiries from investigators regarding this award should be directed to email@example.com. The nomination deadline is Thursday, July 10, 2008.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and 80 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication and its sixth major journal, Cancer Prevention Research, is dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.